
Immunotherapy — using an individual’s own immune system to fight disease — is one of the fastest-growing areas in both human and veterinary research. Here’s the latest.
Ashley Kalinauskas is the CEO of Torigen, a startup biotechnology company focused on providing personalized cancer immunotherapies to companion animals. Torigen is a team of veterinarians and researchers spun out of research from the University of Notre Dame focused on utilizing immunotherapy for cancer and immune-mediated diseases.

Published: July 21st 2020 | Updated: